Dual bio-responsive gene delivery via reducible poly(amido amine) and survivin-inducible plasmid DNA

被引:12
作者
Namgung, Ran [1 ]
Brumbach, Jonathan H. [2 ]
Jeong, Ji Hoon [3 ]
Yockman, James W. [2 ]
Kim, Sung Wan [2 ]
Lin, Chao [4 ,5 ]
Zhong, Zhiyuan [6 ,7 ]
Feijen, Jan [4 ,5 ]
Engbersen, Johan F. J. [4 ,5 ]
Kim, Won Jong [1 ]
机构
[1] Pohang Univ Sci & Technol, Dept Chem, Pohang 790784, South Korea
[2] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Ctr Controlled Chem Delivery, Salt Lake City, UT 84112 USA
[3] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea
[4] Univ Twente, Dept Polymer Chem & Biomat, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands
[5] Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands
[6] Soochow Univ, Biomed Polymers Lab, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China
[7] Soochow Univ, Key Lab Organ Synth Jiangsu Prov, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China
关键词
Dual bio-responsive; Gene therapy; Reducible polymer; Survivin; Tumor cells; ONCOLYTIC ADENOVIRUS; DISULFIDE LINKAGES; MOUSE SURVIVIN; CANCER; APOPTOSIS; PROMOTER; INHIBITION; EXPRESSION; COMPLEXES; THERAPY;
D O I
10.1007/s10529-010-0219-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A bioreducible poly(amido amine) (SS-PAA) gene carrier, known as poly (amido-butanol) (pABOL), was used to transfect a variety of cancer and non-cancer cell lines. To obtain cancer-specific transgene expression for therapeutic efficiency in cancer treatment, we constructed survivin-inducible plasmid DNA expressing the soluble VEGF receptor, sFlt-1, downstream of the survivin promoter (pSUR-sFlt-1). Cancer-specific expression of sFlt-1 was observed in the mouse renal carcinoma (RENCA) cell line. pABOL enhanced the efficiency of gene delivery compared to traditional carriers used in the past. Thus, a dual bio-responsive gene delivery system was developed by using bioreducible p(ABOL) for enhanced intracellular gene delivery and survivin-inducible gene expression system (pSUR-sFlt-1 or pSUR-Luc reporter gene) that demonstrates increased gene expression in cancer that has advantages over current gene delivery systems.
引用
收藏
页码:755 / 764
页数:10
相关论文
共 37 条
[1]   Survivin and apoptosis control [J].
Altieri, DC .
ADVANCES IN CANCER RESEARCH, VOL 88, 2003, 88 :31-52
[2]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[3]  
Bao RD, 2002, J NATL CANCER I, V94, P522
[4]   Tailoring new gene delivery designs for specific targets [J].
Benns, JM ;
Kim, SW .
JOURNAL OF DRUG TARGETING, 2000, 8 (01) :1-12
[5]   Cancer-specific activation of the survivin promoter and its potential use in gene therapy [J].
Chen, JS ;
Liu, JC ;
Shen, L ;
Rau, KM ;
Kuo, HP ;
Li, YM ;
Shi, D ;
Lee, YC ;
Chang, KJ ;
Hung, MC .
CANCER GENE THERAPY, 2004, 11 (11) :740-747
[6]   Side-effects of a systemic injection of linear polyethylenimine-DNA complexes [J].
Chollet, P ;
Favrot, MC ;
Hurbin, A ;
Coll, JL .
JOURNAL OF GENE MEDICINE, 2002, 4 (01) :84-91
[7]   Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery [J].
Christensen, Lane V. ;
Chang, Chien-Wen ;
Kim, Won Jong ;
Kim, Sung Wan ;
Zhong, Zhiyuan ;
Lin, Chao ;
Engbersen, Johan F. J. ;
Feijen, Jan .
BIOCONJUGATE CHEMISTRY, 2006, 17 (05) :1233-1240
[8]   Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].
Dash, PR ;
Read, ML ;
Barrett, LB ;
Wolfert, M ;
Seymour, LW .
GENE THERAPY, 1999, 6 (04) :643-650
[9]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[10]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252